Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia

Br J Haematol. 2013 Jan;160(2):259-61. doi: 10.1111/bjh.12104. Epub 2012 Nov 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / complications
  • Anemia, Sickle Cell / drug therapy
  • Anemia, Sickle Cell / therapy*
  • Blood Transfusion*
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control
  • Cerebral Infarction / etiology
  • Cerebral Infarction / prevention & control
  • Cerebral Revascularization
  • Cerebrovascular Disorders / drug therapy
  • Cerebrovascular Disorders / etiology*
  • Cerebrovascular Disorders / prevention & control
  • Cerebrovascular Disorders / surgery
  • Cerebrovascular Disorders / therapy
  • Child
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Hemoglobins / analysis
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*
  • Leukocyte Count
  • Male
  • Moyamoya Disease / etiology
  • Moyamoya Disease / therapy
  • Retrospective Studies
  • Secondary Prevention
  • Transfusion Reaction

Substances

  • Hemoglobins
  • Hydroxyurea